A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Open Access
- 12 June 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 8972
Abstract
CAR T-cell therapies hold great promise for treating a range of malignancies but are however challenged by the complexity of their production and by the adverse events related to their activity. Here we report the development of the CubiCAR, a tri-functional CAR architecture that enables CAR T-cell detection, purification and on-demand depletion by the FDA-approved antibody Rituximab. This novel architecture has the potential to streamline the manufacturing of CAR T-cells, allow their tracking and improve their overall safety.Keywords
This publication has 30 references indexed in Scilit:
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cellsScience Translational Medicine, 2016
- Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell TransplantationMolecular Therapy, 2016
- Driving CAR T-cells forwardNature Reviews Clinical Oncology, 2016
- Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapyNature Biotechnology, 2016
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell ImmunotherapiesCancer Research, 2015
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2015
- Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivoProceedings of the National Academy of Sciences, 2011
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectorsNature Protocols, 2009
- A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferProceedings of the National Academy of Sciences, 2008
- A Unique Human B Lymphocyte Antigen Defined by a Monoclonal AntibodyHybridoma, 1984